Evotec SE EVO
NASDAQ EVO
$1.81 -0.01 (-0.55%)
At close: Sep 9, 2026 · 4:00 PM EDT

Evotec SE (EVO) Income from Non-Controlling Interests (2009 - 2019)

Evotec SE's (EVO) quarterly Income from Non-Controlling Interests came in at $1.2 million in Q4 2019, up 316.52% quarter-over-quarter from -$550082.1 in Q3 2010.

Analysis

Evotec SE (EVO) Income from Non-Controlling Interests (2009 - 2019) Analysis & Trends

Evotec SE has disclosed Income from Non-Controlling Interests across 3 years of filings, most recently posting $1.2 million for Q4 2019.

  • In Q4 2019, Income from Non-Controlling Interests changed N/A year-over-year to $1.2 million; the TTM figure through Dec 2019 stood at $892312.7 (changed N/A YoY), while the FY2019 annual figure was $945219.1, changed N/A from the prior year.
  • Income from Non-Controlling Interests came in at $1.2 million for Q4 2019 at Evotec SE, up from -$550082.1 in the prior quarter.
  • In the past five years, Income from Non-Controlling Interests ranged from a high of $1.2 million in Q4 2019 to a low of $1.2 million in Q4 2019.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Inc. Minority (Qtr)
1 Iqvia Holdings 44.06 Bn 42.11 Bn 1.44 Bn 2.00 Mn
2 Medpace Holdings 16.50 Bn 16.00 Bn 201.64 Mn -
3 Charles River Laboratories International 13.77 Bn 13.62 Bn 452.07 Mn 722,000.00
4 Icon 12.62 Bn 11.69 Bn 479.29 Mn 19.44 Mn
5 Fortrea Holdings 1.68 Bn 1.51 Bn 139.20 Mn -
6 Evotec SE 661.34 Mn 235.46 Mn - -
7 Ginkgo Bioworks Holdings 442.79 Mn 358.26 Mn 18.44 Mn -
8 Champions Oncology 72.49 Mn 72.62 Mn 7.03 Mn -
9 MindWalk Holdings 61.66 Mn 53.38 Mn 1.82 Mn -
10 VivoSim Labs 1.47 Mn 1.47 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2019 1.19 Mn
Sep 30, 2010 -550,082.14
Jun 30, 2010 200,149.49
Mar 31, 2010 51,234.26
Dec 31, 2009 118,138.74
Jun 30, 2009 247,819.99